BANK OF AMERICA CORP /DE/ - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$15,274,000
+14.6%
427,036
-16.7%
0.01%
+25.0%
Q3 2014$13,330,000
-55.7%
512,692
-43.7%
0.00%
-55.6%
Q2 2014$30,112,000
+146.6%
911,103
+123.4%
0.01%
+125.0%
Q1 2014$12,209,000
-35.3%
407,889
-34.4%
0.00%
-33.3%
Q4 2013$18,874,000
+375.1%
621,695
+397.7%
0.01%
+500.0%
Q3 2013$3,973,000
+162.2%
124,907
+24.6%
0.00%0.0%
Q2 2013$1,515,000100,2750.00%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q3 2014.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders